Peptides for Chronic Lyme: Why I Start With Immune Regulation

For patients with chronic Lyme disease, mast cell activation, or mold illness, the hardest part of treatment is often tolerating it. After fifteen years of treating complex chronic illness, and ten years of using peptides and bioregulators in practice, I’ve found that the order of treatment can matter as much as the treatment itself. Here’s why I often start by stabilizing the immune system before targeting infection, and how peptides fit into that approach.
Is It Lyme, Mold, or Both?

Navigating the uncertainty of potential Lyme disease, mold exposure, or a combination of both can be a challenging and perplexing journey. Dr. Nafysa Parpia sits down with Dr. Ann Shippy to discuss this complex issue and how to begin to understand the steps toward healing.